Herpes Simplex Virus 2 News and Research

RSS
Herpes Simplex Virus-2 is a sexually transmitted viral infection, which often produces painful sores, usually in the genital area. Once infected, an individual may carry the virus and be subject to recurrent bouts of infection. Some estimate that as many as 20 percent of the adult population in the United States has been exposed to the virus.
Epstein-Barr virus might cause multiple sclerosis, study confirms

Epstein-Barr virus might cause multiple sclerosis, study confirms

Novel topically-applied molecular microbicide protects women against HIV infection

Novel topically-applied molecular microbicide protects women against HIV infection

Reprogrammed herpes virus can improve early cancer diagnosis

Reprogrammed herpes virus can improve early cancer diagnosis

African genital herpes strains are more infectious than the U.S. virus

African genital herpes strains are more infectious than the U.S. virus

Non-specific recurring genital symptoms could be undiagnosed herpes

Non-specific recurring genital symptoms could be undiagnosed herpes

Study suggests causal link between HSV1 and Alzheimer's disease

Study suggests causal link between HSV1 and Alzheimer's disease

Journal of Clinical Virology publishes positive outcome from CMX001 treatment against AdV infection

Journal of Clinical Virology publishes positive outcome from CMX001 treatment against AdV infection

Vical 2010 net loss increases to $30.4 million

Vical 2010 net loss increases to $30.4 million

Vical announces issuance of US patent for HSV-2 vaccine

Vical announces issuance of US patent for HSV-2 vaccine

Dermatologists urge athletes to be aware of most common skin infections

Dermatologists urge athletes to be aware of most common skin infections

Targeted delivery combination crosses brain protecting barrier and homes in on tumors

Targeted delivery combination crosses brain protecting barrier and homes in on tumors

IMDx enters multi-year agreement with Abbott Molecular for m2000 instrument system

IMDx enters multi-year agreement with Abbott Molecular for m2000 instrument system

Meganucleases used to prevent HSV-1 infection

Meganucleases used to prevent HSV-1 infection

Chimerix initiates enrollment in CMX001 clinical study for life-threatening conditions caused by dsDNA viruses

Chimerix initiates enrollment in CMX001 clinical study for life-threatening conditions caused by dsDNA viruses

Genocea announces close of $35 million Series B venture financing round

Genocea announces close of $35 million Series B venture financing round

AiCuris announces completion of AIC316 Phase II genital herpes trial

AiCuris announces completion of AIC316 Phase II genital herpes trial

Anti-retroviral therapy yields 'Lazarus effect': Long-term household investment strategy replaces hopelessness

Anti-retroviral therapy yields 'Lazarus effect': Long-term household investment strategy replaces hopelessness

Preclinical trial shows Chimerix’s CMX001 inhibits HSV replication

Preclinical trial shows Chimerix’s CMX001 inhibits HSV replication

Antigenics awarded $424,720 grant under QTDP program

Antigenics awarded $424,720 grant under QTDP program

Chimerix to present CMX001 data for viral infections at IDSA Annual Meeting

Chimerix to present CMX001 data for viral infections at IDSA Annual Meeting